
浏览全部资源
扫码关注微信
1. 湖北省中西医结合医院内分泌科
2. 湖北中医药大学第一临床学院
3. 湖北省中西医结合医院超声科
4. 湖北省中西医结合医院检验科
纸质出版日期:2020,
扫 描 看 全 文
[1]吴淑琼,匡鑫,张静,张众志,陈丹,李银珍,吴勇进.活血散结方对结节性甲状腺肿患者血清白细胞介素1β、白细胞介素6和肿瘤坏死因子α的影响[J].中国医院用药评价与分析,2020,20(11):1304-1306+1311.
WU Shuqiong, KUANG Xin, ZHANG Jing, et al. Effects of Huoxue Sanjie Prescription on Serum Levels of IL-1β,IL-6 and TNF-α in Patients with Nodular Goiter[J]. 2020,20(11):1304-1306.
[1]吴淑琼,匡鑫,张静,张众志,陈丹,李银珍,吴勇进.活血散结方对结节性甲状腺肿患者血清白细胞介素1β、白细胞介素6和肿瘤坏死因子α的影响[J].中国医院用药评价与分析,2020,20(11):1304-1306+1311. DOI: 10.14009/j.issn.1672-2124.2020.11.006.
WU Shuqiong, KUANG Xin, ZHANG Jing, et al. Effects of Huoxue Sanjie Prescription on Serum Levels of IL-1β,IL-6 and TNF-α in Patients with Nodular Goiter[J]. 2020,20(11):1304-1306. DOI: 10.14009/j.issn.1672-2124.2020.11.006.
目的:探讨活血散结方对结节性甲状腺肿患者血清白细胞介素(IL) 1β、IL-6和肿瘤坏死因子α(TNF-α)的影响。方法:将2019年3—6月湖北省中西医结合医院收治的符合纳入标准的40例结节性甲状腺肿患者作为病例组(服用活血散结方
90 d为1疗程
共治疗2个疗程)
同时随机抽取40例来院体检的健康人作为对照组。观察活血散结方的治疗效果;并于治疗前、治疗90 d和180 d时观察结节性甲状腺肿患者血清IL-1β、IL-6和TNF-α水平变化
并与对照组进行对比。结果:治疗后
病例组患者FT3、FT4水平略高于治疗前
高敏促甲状腺激素水平有所降低
差异均无统计学意义(P> 0.05);病例组患者甲状腺体积、结节最大直径均较治疗前明显减小
差异均有统计学意义(P <0.05)。病例组患者治疗前血清IL-1β、TNF-α水平略高于对照组
但差异均无统计学意义(P> 0.05);血清IL-6水平明显低于对照组
差异有统计学意义(P <0.05)。治疗90 d时
病例组患者血清IL-1β、TNF-α水平较治疗前明显升高
差异均有统计学意义(P <0.05);治疗180 d时轻微降低
与治疗90 d时的差异无统计学意义(P> 0.05)
仍明显高于对照组
差异有统计学意义(P <0.05)。病例组患者血清IL-6水平在治疗90 d时有所升高
但与治疗前的差异无统计学意义(P> 0.05);治疗180 d时已升至正常范围
与治疗90 d时及治疗前相比
差异均有统计学意义(P <0.05)
与对照组比较的差异无统计学意义(P> 0.05)。结论:活血散结方可能通过适度升高结节性甲状腺肿患者血清IL-1β、IL-6及TNF-α水平来起到治疗作用。
OBJECTIVE: To probe into the effects of Huoxue Sanjie prescription on serum levels of IL-1β
IL-6 and TNF-α in patients with nodular goiter. METHODS: A total of 40 patients with nodular goiter admitted to Hubei Provincial Hospital of Integrated Chinese and Western Medicine from Mar. 2019 to Jun. 2019 were selected as the case group( received Huoxue Sanjie prescription
with 90 d for one course of treatment
totally 2 courses of treatment). Meanwhile
40 healthy people who came to the hospital for physical examination were randomly selected as the control group. The therapeutic effects of Huoxue Sanjie prescription were observed
the serum levels of IL-1β
IL-6
and TNF-α of patients with nodular goiter were observed before treatment
and after treatment of 90 d and 180 d were observed and compared with the control group. RESULTS: After treatment
the levels of FT3 and FT4 in the case group were higher than those before treatment
and the level of s TSH decreased
with no statistically significant difference( P > 0. 05). The thyroid volume and maximum diameter of nodules in the case group decreased significantly compared with those before treatment
and the differences were statistically significant( P < 0. 05). The levels of IL-1β and TNF-α in the case group were higher than those in the control group before treatment
yet the difference was not statistically significant( P > 0. 05); the level of IL-6 was significantly lower than that in the control group
and the difference was statistically significant( P < 0. 05). After treatment of 90 d
the levels of IL-1β and TNF-α in the case group were significantly higher than those before treatment
and the differences were statistically significant( P < 0. 05).After treatment of 180 d
the levels of IL-1β and TNF-α in the case group slightly decreased
with no statistically significant difference compared with those after treatment of 90 d( P > 0. 05)
which were still significantly higher than those of the control group
with statistically significant difference( P < 0. 05). The level of IL-6 in the case group increased after treatment of 90 d
but there was no statistically significant difference compared with before treatment( P >0. 05)
it had risen to the normal range after treatment of 180 d
and compared with after treatment of 90 d and before treatment
the difference was statistically significant( P < 0. 05)
and the difference was not statistically significant compared with the control group( P > 0. 05). CONCLUSIONS: Huoxue Sanjie prescricption may play a therapeutic role by moderately increasing the serum levels of IL-1β
IL-6 and TNF-α in patients with nodular goiter.
活血散结方结节性甲状腺肿IL-1βIL-6TNF-α
Huoxue Sanjie prescriptionNodular GoiterIL-1βIL-6TNF-α
0
浏览量
40
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621